Electromed, Inc. (ELMD) Q1 Revenue Rises 10.6% and Net Income 29.3%
Electromed, Inc. reported Q1 FY 2027 revenue of $18.7M, up 10.6% YoY, and net income of $2.8M, up 29.3% YoY. Diluted EPS was $0.32, compared to $0.25 in the prior year. This marks the 16th consecutive quarter of year-over-year growth for the company, according to the company.
How this was made
The 30-second read
Why it matters
The earnings beat reinforces a 16‑quarter streak of growth, likely prompting short‑term buying interest.
Market read
First‑time earnings disclosure for a small‑cap; modest trading relevance.
What to watch
Cash burn and need for additional financing are not disclosed but could limit upside.
Background
Electromed, Inc. (ELMD) is a micro‑cap medical‑device company that reported its Q1 FY2027 results via BusinessWire.
Ticker impact
Q1 FY2027 revenue rose 10.6% YoY to $18.7M and net income jumped 29.3% to $2.8M, marking the first public disclosure of the quarter's results.
likely modest upside as investors price in continued growth trend.
Small‑cap earnings beat; growth momentum may attract short‑term buying, but limited liquidity caps move size.
Market effects
Signals strength in the niche medical‑device segment, potentially supporting peers.
Limited to U.S. micro‑cap space; no broader regional effect.
Minimal; relevance confined to investors tracking small‑cap biotech/med‑tech.
Counterpoint
Growth may be unsustainable; high‑cost structure could pressure future margins.
Key entities
- companyElectromed, Inc.
US‑listed medical‑device firm (ticker ELMD).
